The primary objective of the Live Cell Imaging Core (LCIC) is to facilitate research by COBRE Lung Biology Center (LBC) investigators on chronic bacterial infections of the lungs and to develop new approaches to treat these diseases. The infrastructure and scientific expertise of the LCIC supports live-cell imaging, including visualization of intracellular protein localization and host-microbe interaction studies.
The specific aims of the LCIC are to: (1) Provide expertise and technical support for studies imaging the co-culture biofilm model of host-pathogen interactions developed at Dartmouth, (2) Develop and apply novel and established imaging approaches to understand the impact of infections on protein trafficking, localization, and assembly in airway epithelial cells and immune cells, and (3) Continue a trajectory to financial sustainability by the end of COBRE III, enabling the Core to continue providing imaging services and expertise to LBC investigators, as well as to Dartmouth and IDeA partners. Since its formation in 2010, the LCIC has made significant contributions to 13 research projects, including those conducted by junior faculty project leaders, faculty in the LBC funded by pilot projects, and LBC projects conducted in collaboration with 7 industrial partners. LBC faculty have indicated in the 2012 yearly review that their current usage of the LCIC will continue, and overall usage is likely to increase due to faculty hiring and new pilot projects: 10 out of 15 responses to our preliminary RFA will utilize the LCIC. Bruce A. Stanton, Ph.D., the Andrew C Vail Professor of Microbiology and Immunology, will direct the Core. He has over 34 years of experience in biological imaging. The core manager, Qianru Yu, Ph.D. is also an expert in biological imaging and will continue to facilitate use of the Core Olympus and Nikon LSC live cell imaging workstations by LBC investigators. In COBRE II we have developed a highly successful plan of LCIC evaluation, quality control, resource evaluation, investigator education, training and outreach. As a result, we are in an exceptionally strong position to build on our track record of supporting research on host-pathogen interactions, the respiratory microbiome in CF, drug discovery and therapeutic development for respiratory infectious diseases in COBRE III and beyond.

Public Health Relevance

Infectious respiratory diseases are the third leading cause of death in the U.S. The studies described in this application will lead to a better understanding of how opportunistic pathogens, including Pseudomonas aeruginosa, cause chronic respiratory infections, and to new drugs / therapies to treat infectious respiratory disease.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1-TWD-C)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Dartmouth College
United States
Zip Code
Facciponte, Dominic N; Bough, Matthew W; Seidler, Darius et al. (2018) Identifying aerosolized cyanobacteria in the human respiratory tract: A proposed mechanism for cyanotoxin-associated diseases. Sci Total Environ 645:1003-1013
Grahl, Nora; Dolben, Emily L; Filkins, Laura M et al. (2018) Profiling of Bacterial and Fungal Microbial Communities in Cystic Fibrosis Sputum Using RNA. mSphere 3:
Hvorecny, Kelli L; Dolben, Emily; Moreau-Marquis, Sophie et al. (2018) An epoxide hydrolase secreted by Pseudomonas aeruginosa decreases mucociliary transport and hinders bacterial clearance from the lung. Am J Physiol Lung Cell Mol Physiol 314:L150-L156
Torres, Iviana M; Patankar, Yash R; Berwin, Brent (2018) Acidosis exacerbates in vivo IL-1-dependent inflammatory responses and neutrophil recruitment during pulmonary Pseudomonas aeruginosa infection. Am J Physiol Lung Cell Mol Physiol 314:L225-L235
Dhingra, Sourabh; Buckey, Jay C; Cramer, Robert A (2018) Hyperbaric Oxygen Reduces Aspergillus fumigatus Proliferation In Vitro and Influences In Vivo Disease Outcomes. Antimicrob Agents Chemother 62:
Ries, Laure Nicolas Annick; Beattie, Sarah; Cramer, Robert A et al. (2018) Overview of carbon and nitrogen catabolite metabolism in the virulence of human pathogenic fungi. Mol Microbiol 107:277-297
Beattie, Sarah R; Mark, Kenneth M K; Thammahong, Arsa et al. (2017) Filamentous fungal carbon catabolite repression supports metabolic plasticity and stress responses essential for disease progression. PLoS Pathog 13:e1006340
Stanton, Bruce A (2017) Effects ofPseudomonas aeruginosaon CFTR chloride secretion and the host immune response. Am J Physiol Cell Physiol 312:C357-C366
Hvorecny, Kelli L; Bahl, Christopher D; Kitamura, Seiya et al. (2017) Active-Site Flexibility and Substrate Specificity in a Bacterial Virulence Factor: Crystallographic Snapshots of an Epoxide Hydrolase. Structure 25:697-707.e4
Bertrand, Carol A; Mitra, Shalini; Mishra, Sanjay K et al. (2017) The CFTR trafficking mutation F508del inhibits the constitutive activity of SLC26A9. Am J Physiol Lung Cell Mol Physiol 312:L912-L925

Showing the most recent 10 out of 64 publications